USPTO 2015–2025 USPTO PatentsView US Corporation

Stratos Genomics, Inc.

USPTO PatentsView assignee record - 14 granted patents across 9 technology areas, recorded in grant years 2017–2023. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr).

RSS updates for this company

The verdict

According to USPTO PatentsView, Stratos ranks #20,469 of 49,997 tracked US assignees by granted-patent volume, with 14 patents across 9 technology areas.

#20,469
of 49,997 US assignees by volume
37th percentile
by Innovation Score (31.2/100)
14.5
avg claims per patent
+33%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R20469 · US Corporation #20,469 · 14 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-UP · BOOK-FULL

  • GRANTS-MICRO 14 grants
  • MID-PACK #20,469/49,997
  • PHOTO-FINISH Sterno Home
  • CPC-NARROW C12Q · 9 areas
  • INNOV-THIN 31.2/100
  • CLAIMS-RICH 14.5 claims/avg
  • TYPE-USCORP US Corporation
  • VEL-UP +33% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Sterno Home Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Stratos’s 31.2 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Stratos

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Stratos's Innovation Score is 31.2/100 (37th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Stratos?

Each dot is one of Stratos’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Stratos’s own 14.5 claims/patent is at or below the 14.9 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Stratos vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 13.913.91414.1 05101520 Granted patents (volume) Avg claims / patent Sterno Home Inc. - 14, 14.93Sterno HomeStichting Het Nederlands Kanker Instituut—Antoni Van Leeuwenhoek Ziekenhis - 14, 17.07Stichting Het Ned…Stoller Enterprises, Inc. - 14, 14.71Stoller Enterpris…Stoneridge Control Devices, Inc. - 14, 18.36Stoneridge Contro…Strawberry Sciences, LLC - 14, 1Strawberry Scienc…Sumita Optical Glass, Inc. - 14, 6.36Sumita Optical Gl…Sunlighten, LLC - 14, 17.79SunlightenSuperTurbo Technologies, Inc. - 14, 17.07SuperturboStratos Genomics, Inc. - 14, 14.5Stratos Genomics
Stratos vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Stratos's grants concentrate

Stratos Genomics, Inc. is a focused PatentsView assignee: 9 CPC subclasses with 50% of grants classified under C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr). Peak complete grant year is 2020 (4 grants) versus a trough of 1 in 2018. By volume, Stratos sits between Sterno Home Inc. and SuperTurbo Technologies, Inc..

Stratos's three-year grant acceleration

Stratos Genomics, Inc. shows 3 grants in 2022–2024 against only 8 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Stratos's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Stratos holds 14 patents at rank #20,469, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Stratos

By rank, the assignees closest to #20,469 in granted patent volume.

Leaders in C12Q (Measuring OR Testing Processes Involving Enzymes)

Other assignees with the most granted patents in Stratos's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Stratos, neither rank-band nor same-CPC leaders (those blocks stay above). In C12Q (Measuring OR Testing Processes Involving Enzymes), Stratos ranks #618 of 2,502 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (31 here).

Stratos's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

31 37th percentile higher than 37% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

012345 2017201820192020202120222023 1
USPTO utility patent grants by year · 2017–2023

Grants by year

Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.

View data table
Stratos Genomics, Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2017 2 14.3%
2018 1 7.1%
2019 3 21.4%
2020 4 28.6%
2021 1 7.1%
2022 2 14.3%
2023 1 7.1%

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

Stratos Genomics, Inc.'s patent record in context - here's where to go next.

  • Stratos Genomics, Inc.'s lead technology class is C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr), 50% of its portfolio - see every assignee active in that class. Explore C12Q
  • Ranked #20,469 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Stratos Genomics, Inc. against Sterno Home Inc., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 31.2/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.